|
9
|
|
Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function.
(linkinghub.elsevier.com)
|
Takacsi-Nagy O
…
Satpathy AT
Cell
2026-08-19
|
#immunotherapy
#protein design
#car-t
#transcriptomics
#epigenetics
|
|
6
|
|
Rewiring immunity with in vivo CAR T cell engineering.
(nature.com)
|
Slaney CY
…
Darcy PK
Nature Cancer
2026-08-21
|
#immunotherapy
#car-t
#oncology
#engineering
#lymphocyte
|
|
5
|
|
Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.
(nature.com)
|
von Wardenburg N
…
Pruss H
Nature Communications
2026-08-20
|
#immunotherapy
#autoimmune
#myasthenia
#car-t
#autoantibodies
|
|
5
|
|
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.
(nature.com)
|
Broske B
…
Holzel M
Nature Communications
2026-08-20
|
#protein design
#ai
#immunotherapy
#cancer
#car-t
|
|
5
|
|
Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.
(linkinghub.elsevier.com)
|
Hegelmaier T
…
Haghikia A
Cell Reports Medicine
2026-08-21
|
#immunotherapy
#autoimmune
#myasthenia
#car-t
#remission
|
|
3
|
|
A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.
(science.org)
|
Georgiadis C
…
Qasim W
Science Translational Medicine
2026-08-19
|
#immunotherapy
#leukemia
#car-t
#base-editing
#transplantation
|
|
2
|
|
Neutrophil-integrated syncytial CAR macrophage for cancer immunotherapy.
(nature.com)
|
Tian T
…
Zhang Z
Nature Immunology
2026-08-18
|
#immunotherapy
#car-t
#macrophage
#oncology
#neutrophil
|
|
0
|
|
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.
(nature.com)
|
Paruzzo L
…
Ruella M
Nature Medicine
2026-08-10
|
#car-t
#lymphoma
#immunotherapy
#persistence
#transcriptomics
|
|
0
|
|
Gone but not forgotten: CAR-NK cells leave a lasting mark on autoimmunity.
(linkinghub.elsevier.com)
|
Shrestha R
…
Basar R
Cell Med
2026-08-14
|
#immunotherapy
#autoimmunity
#car-t
#lupus
#b cell
|
|
0
|
|
Calibration of CAR signaling promotes asymmetric cell division to direct CAR-T cell fate and antitumor potency.
(linkinghub.elsevier.com)
|
Shen X
…
Sun J
Cell Reports
2026-08-14
|
#car-t
#immunotherapy
#cell-division
#t cell
#cancer
|
|
0
|
|
Discovery and design of potent cell surface display elements.
(nature.com)
|
Fang Z
…
Chen S
Nature Biotechnology
2026-08-12
|
#cell-surface-display
#immunotherapy
#deep learning
#protein design
#car-t
|
|
0
|
|
Preclinical evaluation of nitrated alpha-synuclein-specific CAR-Treg therapy in Parkinson's disease.
(linkinghub.elsevier.com)
|
Ugalde V
…
Pacheco R
Cell Reports Medicine
2026-08-12
|
#immunotherapy
#neuroinflammation
#neurodegeneration
#car-t
|
|
0
|
|
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Zhang Y
…
Huang G
Nature Medicine
2026-08-06
|
#immunotherapy
#glioblastoma
#car-t
#clinical trial
#oncology
|
|
0
|
|
Tunable universal OR-gated CAR T cells for AML.
(linkinghub.elsevier.com)
|
Siddiqui MY
…
Wong WW
iScience
2026-08-04
|
#car-t
#leukemia
#immunotherapy
#synthetic biology
#antigen
|
|
0
|
|
Robust CD4(+) CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
(science.org)
|
Jurgens EM
…
Mailankody S
Science Translational Medicine
2026-07-29
|
#car-t
#immunotherapy
#toxicity
#myeloma
#neurotoxicity
|